Mr. Dimon is the venture’s only leader who could bring the iPhone maker into the trio’s healthcare business, which is led by Harvard Medical School professor and surgeon Atul Gawande, MD, because Berkshire owns a large stake in Apple stock. It would be “self-serving” for Berkshire CEO Warren Buffett, whose charitable trust also owns shares of Apple, to scoop up the tech giant, Mr. Cramer added.
“It is really time for, I think, that ecosystem to embrace the Apple ecosystem,” Mr. Cramer said. Historically, he has advised stakeholders not to sell Apple’s stock, and predicts it will eventually bottom out at $120 per share, CNBC reports.
More articles on health IT:
Why healthcare pulled back from blockchain in 2018 & what to expect this year: Q&A with Solaster CEO Stuart Lackey
Challenges & barriers to blockchain adoption in healthcare: Q&A with CTG Health Solutions principal consultant
3 key insights on the appeal of blockchain: Q&A with LexisNexis Health Care senior VP
